罗伯特·A·温恩（Robert A. Winn）临床试验奖的多样性Program Established by the Bristol Myers Squibb Foundation To Expand With Amgen’s Commitment of $8 Million
Amgen加入Gilead Sciences作为计划支持者
现在为医生和医学生开放申请
Originally published on Bristol Myers Squibb News & Perspectives
新泽西州普林斯顿，2023年1月19日 / 3BL媒体 /罗伯特·A·温恩（Robert A. Winn）临床试验奖的多样性Program（Winn Award Program）由Bristol Myers Squibb Foundation(BMSF) announced that Amgen, a global biotechnology company, has committed to contribute $8 million over the next four years. This contribution will enable the program to reach additional physicians and medical students, further expanding the initiative that aims to extend the reach of clinical trials in underserved patient populations in U.S. communities.
迄今为止，Winn Award计划已经培训了114名早期研究员医师，并且为44名来自不同种族和种族背景的医学生提供了基于社区的临床研究的身临其境的经验。188bet网址怎么打不开现在正在接受医生的申请third cohortof its Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA) and from medical students for thesecond cohortof its Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Pathway Program (Winn CIPP) Award. With the additional support from Amgen, it is set to reach more than 300 diverse and community-oriented clinical investigators and 300 diverse medical students by 2027.
“借助他们参加Winn奖计划的技能，经验和网络，这些非凡的医生和学生将在美国提供医疗保健的方式上有重大影响。”Amgen代表临床研究（RISE）计划。“支持致力于卫生公平的医生和医学生，并强调在职业生涯的早期临床试验中增加多样性的需求是改善所有人健康的重要一步。”
临床试验的多样性是医疗保健方面的长期挑战，目前，临床研究试验的80％的参与者是白人。Food and Drug Administration。Lack of diversity in clinical trials hinders the ability to eliminate health disparities and ensure medicines are safe and effective for all patients. To address this issue, the BMSF created the Winn Award Program in 2020 as part of its commitment to health equity, inclusion and diversity. The BMSF chose Virginia Commonwealth University (VCU) as the program implementation partner and the American Association for Cancer Research (AACR) as a curriculum partner to deliver The Robert A. Winn – AACR Design and Implementation of Clinical Trials Workshop, the first training the Winn CDA scholars receive. The program is named in honor of Robert A. Winn, M.D., Director and Lipman Chair in Oncology, VCU Massey Cancer Center and Chair of the Winn Award Program National Advisory Committee.
“It is no secret that the current state of clinical research does not reflect the diversity of the U.S. population,” said John Damonti, President, Bristol Myers Squibb Foundation (BMSF). “Substantial, lasting change can be accomplished only if everyone is a part of this movement in diversifying healthcare. As we strive to ensure that safe and effective medicines and therapies are available for all across the nation, we are honored to have Amgen serve as a supporter of the Winn Award Program in achieving this vision.”
BMSF承诺在该计划的范围内支持250个Winn CDA和250个Winn Cipps。2022年，吉利德科学（Gilead Sciences）提供了1400万美元的支持，其中包括10个Winn CDA和四年的每年10个Winn Cipps。
吉利德科学公司首席医学官Merdad Parsey博士说：“ Gilead很高兴欢迎Amgen参加Winn奖计划。”“在吉利德，我们致力于为每个人创造一个更健康的世界。通过对临床试验科学家的培训和开发进行投资，我们认识到并支持变革性的医疗突破，同时扩大到更多的患者人群和社区的影响力。”
The Winn Award Program currently offers two awards: the Winn CDA, a two-year program designed to support diverse physicians and those who have demonstrated commitment to increasing diversity in clinical trial research within their local communities, and the Winn CIPP, a six-week summer externship during which diverse medical students are provided an immersive experience in community-based clinical research. The Winn Award Program encourages others in the healthcare industry to consider participating as faculty and/or sponsors. Interested parties can learn more about the program atdiversityinclinicaltrials.organd contact the team atwinnawardinfo@vcu.edu。
About the Bristol Myers Squibb Foundation
独立的慈善组织布里斯托尔·迈尔斯·斯奎布基金会（Bristol Myers Squibb Foundation）专注于最有可能受到严重疾病影响的社区，这受到最严重打击。它使合作伙伴有能力开发和测试创新的解决方案，以提高健康公平并改善患者获得优质医疗保健的机会。赠款的重点是癌症，心血管疾病和免疫疾病，以及美国的临床试验多样性，以及巴西和中国九个非洲国家的普遍癌症。布里斯托尔·迈尔斯（Bristol Myers Squibb）基金会的使命是促进健康公平，并通过增强医疗保健工作者的能力，整合医疗保健和基于社区的支持服务，并在打击疾病的斗争中动员社区，从而改善受严重疾病影响不成比例的人群的健康成果。188bet网址怎么打不开188bet上不了有关更多信息，请访问Bristol Myers Squibb基金会（BMS.com）。
关于弗吉尼亚联邦大学
Virginia Commonwealth University (VCU) is a major, urban public research university with national and international rankings in sponsored research. Located in downtown Richmond, VCU enrolls nearly 29,000 students in 238 degree and certificate programs in the arts, sciences and humanities. Twenty-three of the programs are unique in Virginia, many of them crossing the disciplines of VCU’s 11 schools and three colleges. For more, please visitvcu.edu。
About the American Association for Cancer Research
美国癌症研究协会（AACR）成立于1907年，是世界上第一个也是最大的专业组织，致力于促进癌症研究及其使命，以预防和治愈癌症。AACR成员包括超过52,000个实验室，转化和临床研究人员；人口科学家；其他医疗保健专业人员；和居住在130个国家 /地区的患者拥护者。AACR通过每年每年召开30多次会议和教育研讨会，这是癌症界的全部专业知识，以加快预防，诊断和治疗癌症的进展，其中最大的是AA188bet网址怎么打不开CR年会。此外，AACR还出版了10本著名的，同行评审的科学期刊和癌症幸存者，患者及其护理人员的杂志。AACR直接资助了有功的研究以及与众多癌症组织的合作。作为抗癌的科学合作伙伴，AACR提供了专家同行评审，拨款管理以及对团队科学和癌症研究中个人研究人员的科学监督，这些研究有可能获得近期患者的利益。AACR积极与立法者和其他政策制定者进行沟通，涉及癌症研究和相关生物医学对挽救癌症生命的价值。 For more information about the AACR, visitwww.AACR.org。
About Gilead Sciences, Inc.
Gilead Sciences，Inc。是一家生物制药公司，在三十年中一直在医学领域取得突破，目的是为所有人创造一个更健康的世界。该公司致力于推进创新的药物，以预防和治疗威胁生命的疾病，包括艾滋病毒，病毒肝炎和癌症。吉利德（Gilead）在全球35个国家 /地区开展业务，总部位于加利福尼亚州福斯特市。
公司慈善事业新闻
Media:media@bms.com
Source: Bristol Myers Squibb
